Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

4.8K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
4.8K
Metastasis02:30

Metastasis

6.8K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
Oogenesis02:07

Oogenesis

71.2K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
71.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

8.1K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic assessment of two novel proliferation-specific antigens in benign and malignant melanocytic lesions.

The American journal of pathology·1995
Same author

[Placental site trophoblastic tumor. Morphology, differential diagnosis and prognosis].

Der Pathologe·1995
Same author

Retinal vascular hamartoma in von Hippel-Lindau disease.

Archives of ophthalmology (Chicago, Ill. : 1960)·1995
Same author

Dosimetry of iodine-123-epidepride: a dopamine D2 receptor ligand.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·1995
Same author

The use of CD31 and collagen IV as vascular markers. A study of 56 vascular lesions.

Pathology, research and practice·1995
Same author

[Fatigue fractures of the sacrum in primary biliary liver cirrhosis].

Aktuelle Radiologie·1995
Same journal

Consensus on the Management of Inavolisib Side Effects. A Survey on Defined Side Effects, the Assumed Pathomechanism, Preventative and/or Therapeutic Measures Including the Integration of Additional Health Care Professionals - a Consensus Paper.

Geburtshilfe und Frauenheilkunde·2026
Same journal

Statement by the Uterus Commission of the Arbeitsgemeinschaft Gynäkologische Onkologie [German Gynecological Oncology Group] (AGO) on the ESGO-ESTRO-ESP Guideline 2025.

Geburtshilfe und Frauenheilkunde·2026
Same journal

Feasibility of <i>PIK3CA</i> Mutation Detection via Microfluidic Isolation of Disseminated Tumor Cells from Bone Marrow in Breast Cancer Patients.

Geburtshilfe und Frauenheilkunde·2026
Same journal

Stereotactic Vacuum-Assisted Biopsy in Photon-Counting Dedicated Spiral Breast CT: A Proof of Concept.

Geburtshilfe und Frauenheilkunde·2026
Same journal

RSV Prophylaxis in Neonates: Implementation and Parental Acceptance during the First RSV Season in Germany.

Geburtshilfe und Frauenheilkunde·2026
Same journal

Genital Herpes Simplex Virus (HSV) Infection During Pregnancy - Recommendations of the Working Group on Obstetrics and Prenatal Medicine (AGG - Section on Maternal Disorders).

Geburtshilfe und Frauenheilkunde·2026
See all related articles

Related Experiment Video

Updated: Mar 24, 2026

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction
05:42

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction

Published on: January 26, 2024

3.3K

Endometriosis-associated Malignancy.

N Krawczyk1, M Banys-Paluchowski2, D Schmidt3

  • 1Department of Obstetrics and Gynecology, University of Düsseldorf, Düsseldorf.

Geburtshilfe Und Frauenheilkunde
|March 5, 2016
PubMed
Summary
This summary is machine-generated.

Endometriosis may increase cancer risk, particularly in the ovaries. Endometriosis-associated malignancy (EAM) research is ongoing to understand this rare condition and its genetic links.

Keywords:
atypical endometriosisendometriosisendometriosis-associated malignancymalignant transformationovarian cancer

More Related Videos

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time
14:25

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time

Published on: May 20, 2014

17.9K
Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
10:58

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

11.6K

Related Experiment Videos

Last Updated: Mar 24, 2026

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction
05:42

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction

Published on: January 26, 2024

3.3K
Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time
14:25

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time

Published on: May 20, 2014

17.9K
Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
10:58

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

11.6K

Area of Science:

  • Gynecology
  • Oncology
  • Pathology

Background:

  • Endometriosis is a common condition in reproductive-aged women.
  • Epidemiological studies suggest a potential association between endometriosis and an increased risk of various malignancies.
  • Endometriosis-associated malignancy (EAM) is defined by specific histological criteria.

Approach:

  • This study focuses on endometriosis-associated malignancies (EAM), including those in ovarian and extragonadal sites.
  • Investigates potential intermediate lesions between endometriosis and cancer.
  • Examines genetic alterations like LOH, PTEN, ARID1A, and p53 mutations found in both endometriosis and EAM.

Key Points:

  • Approximately 80% of EAM occur in the ovary, while 20% are found in extragonadal sites (e.g., intestine, rectovaginal septum, abdominal wall, pleura).
  • Endometriosis-associated ovarian cancer (EAOC) typically presents as well or intermediately differentiated endometrioid or clear cell tumors.
  • Patients with EAOC are often younger and diagnosed with low-stage disease, suggesting a favorable prognosis.

Conclusions:

  • EAM is a rare condition, and systematic data are currently limited.
  • A systematic retrospective study on EAM is underway, involving the Endometriosis Research Foundation and the working group for gynecological oncology (AGO).
  • Further research is needed to fully understand the pathogenesis and clinical implications of EAM.